Apellis Pharmaceuticals's total assets for Q2 2025 were $821.39M, an increase of 1.75% from the previous quarter. APLS total liabilities were $665.09M for the fiscal quarter, a 3.42% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.